摘要
目的 探讨思连康、甘草锌制剂联合思密达治疗小儿腹泻病的临床疗效.方法 选择104例腹泻患儿,随机分为对照组与治疗组,均给予对症处理和口服思密达,治疗组加用思连康及甘草锌冲剂,比较两组治疗效果.结果 对照组的总有效率为76.92%,与治疗组的92.31%比较差异有统计学意义（χ2=4.727,P〈0.05）.治疗组平均治愈时间短于对照组,两组比较差异亦有统计学意义（t=2.423,P〈0.05）.结论 思连康、甘草锌冲剂联合肠粘膜保护剂思密达治疗小儿急性腹泻,能够缩短腹泻时间,提高治愈率,具有重要的临床意义.
Objective To determine the clinical therapeutic efficacy of siliankang and licorzinc combined with smecta in pediatric diarrhea. Methods 104 cases with pediatric diarrhea were randomly divided into two groups： control and experimental group. Both groups were given symptomatic treatment and smecta orally. Besides, siliankang and licorzinc were given to experimental group. The therapeutic efficacy of two groups was compared. Results The total effective rates of control group and experimental group were 76. 92% and 92. 31% respectively, and the difference was significant （χ2 = 4.727, P 〈 0.05）. The average cure time of experimental group was shorter than that of control group, and there was also significant difference （ t = 2. 423, P 〈 0.05 ）. Conclusion The combination regimen of siliankang, licorzinc and smecta can remarkably shorten diarrhea period and improve cure rate. It has important clinical significance.
出处
《中国妇幼健康研究》
2011年第5期666-667,共2页
Chinese Journal of Woman and Child Health Research
关键词
思连康
甘草锌
思密达
小儿腹泻
siliankang
licorzinc
smecta
pediatric diarrhea
